Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Acq. announced
Director departure
|
|
Graf Acquisition Corp. IV
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Graf Acquisition Partners IV LLC (10% Owner) has filed a Form 4 on NKGen Biotech, Inc.|
Txns:
| Disposed of 1,773,631 shares
@ $0
Granted 4,721,533 options to buy
@ $11.5, valued at
$54.3M
Granted 523,140 options to buy
@ $11.5, valued at
$6M
|
|
| 07/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2021 |
4
| Garcia Gus (Co-President) has filed a Form 4 on Graf Acquisition Corp. IV|
Txns:
| Bought 600 shares
@ $9.93, valued at
$6k
Bought 900 shares
@ $9.92, valued at
$8.9k
|
|
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|